FIELD: medicine.
SUBSTANCE: method comprises measuring in peripheral blood antibody titre to CMV and phosphodiesterase and adenylate cyclase activity in membrane syncytiotrophoblast and estriol content in homogenate of placenta, and titre of antibodies to CMV 1:1600, reduction in membrane adenylate cyclase to syncytiotrophoblast 10.0±0.2 conventional units, increased activity in membrane of syncytiotrophoblast phosphodiesterase to 18.00±0.31 conventional units and reducing content of estriol in placenta homogenate to 177.50±7.80 nmol/l is a threat to formation of placental insufficiency.
EFFECT: invention can be used to diagnose formation of placental insufficiency at an exacerbation of cytomegalovirus infection in third trimester of gestation.
1 cl, 2 dwg
Authors
Dates
2016-04-10—Published
2015-05-15—Filed